Guardant Health GH
NASDAQ GH
$168.40 -2.51 (-1.47%)
As of: Aug 27, 2026 · 3:59 PM EDT

Guardant Health (GH) Deferred Taxes (2019)

Guardant Health (GH) posted Deferred Taxes of -$2.8 million for Q4 2019.

Guardant Health (GH) Deferred Taxes (2019) Analysis & Trends

Guardant Health has reported Deferred Taxes for 1 years, with the latest figure at -$2.8 million in Q4 2019.

  • Quarterly Deferred Taxes changed N/A year-over-year to -$2.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2020 was -$2.8 million (changed 0.0% YoY) and the FY2022 annual result came in at $99.8 million, changed N/A from the prior year.
  • Deferred Taxes was little changed at -$2.8 million in Q4 2019 per GH's latest filing.
  • Over five years, Deferred Taxes peaked at -$2.8 million in Q4 2019 and troughed at -$2.8 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -208.00 Mn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 32.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -36.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 6.54 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -21.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 1.82 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -24.40 Mn
10 Guardant Health 22.38 Bn 21.33 Bn 219.03 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 -2.83 Mn